Convergence Seminar
Tuesday, February 17, 2026

Le Cong, PhD

Department of Pathology and Genetics, Stanford University

Le Cong's work has led to one of the first CRISPR/Cas9 gene-editing tools for in vivo gene therapy. More recently, his group invented tools for cleavage-free large gene insertion with novel recombination proteins (SSAP editor), and developed machine-learning optimized single-cell methods (DAISY) for studying cancer and immune diseases. Cong is a recipient of the NHGRI Genomic Innovator Award, Baxter Foundation Faculty Scholar, Genetic Engineering and Biotechnology News (GEN) Top 10 Under 40, Clinical OMICs Pioneers Under 40, and Clarivate Web of Science Highly Cited Researcher.

Details

Dates
February 17, 2026
Time
11:00am-12:00pm PST
Location
Mahley Auditorium
Contact(s)





The Convergence Seminar is organized by Gladstone’s Institute for Data Science and Biotechnology. This seminar series brings together scientists from varying disciplines to solve complex scientific questions and accelerate the path to cures.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.